Total Funding
30
38
Total FundingPost-IPO Equity raised
Growth Score 30 in past quarter
-13 pts
Heat Score 38 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
246859
CannaPharmaRx operates within the healthcare community as a leader in the Endocannabinoid System (ECS) research and development.
- Andrew Steedman: COO
- John Cassels: CFO
About the Company
CannaPharmaRx operates within the healthcare community as a leader in the Endocannabinoid System (ECS) research and development.

